Reaction
Haemorrhagic Transformation Stroke reporting signals
As of the last recalculation, Haemorrhagic Transformation Stroke appears in 1,483 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is ALTEPLASE (PRR 571.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alteplase | 433 | 571.3 | 588.3 |
| Dabigatran Etexilate Mesylate | 141 | 30.0 | 30.1 |
| Dabigatran Etexilate | 144 | 28.7 | 28.8 |
| Labetalol | 24 | 25.7 | 25.7 |
| Rivaroxaban | 284 | 23.4 | 23.5 |
| Dutasteride | 11 | 19.1 | 19.1 |
| Nebivolol | 17 | 15.1 | 15.2 |
| Clopidogrel Bisulfate | 103 | 15.1 | 15.1 |
| Enoxaparin Sodium | 52 | 13.1 | 13.1 |
| Tranexamic Acid | 7 | 11.1 | 11.1 |
| Heparin Sodium | 9 | 9.2 | 9.2 |
| Clopidogrel | 117 | 8.9 | 8.9 |
| Drospirenone And Ethinyl Estradiol | 12 | 3.8 | 3.8 |